L26/P-454 Marked ethnic disparities in IVF outcomes result in significantly reduced live birth rates in ethnic minority groups
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.788 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von S. Hanassab und 14 weiteren Autor:innen.
Abstract (Originalsprache)
Study question How do IVF treatment outcomes in the UK differ by ethnicity, and to what extent are disparities explained by pre-treatment prognostic and socioeconomic factors? Summary answer The adjusted odds of live birth after fresh and frozen embryo transfer (FET) were significantly reduced in ethnic minority groups, especially in Black women. What is known already Women from ethnic minority background have reduced live birth rates compared with patients of White ethnicity, however the precise reasons for this remain unclear. Pre-treatment factors such as age at accessing treatment, body mass index (BMI), infertility diagnosis, ovarian reserve, comorbidities, and variation in care pathways contribute to the observed disparity. Socioeconomic disadvantage and funding source (i.e., privately or publicly funded) may also influence how quickly treatment is accessed. Currently, there are only limited analyses with sufficient diversity and clinical detail to enable adjustment for important treatment-related and socioeconomic factors and to identify the stage of treatment affected. Study design, size, duration We performed retrospective cohort analyses using two complementary UK datasets. Cohort 1: national Human Fertilisation and Embryology Authority (HFEA) registry data captured 358,732 patients starting treatment between 2008-2023. Cohort 2: a detailed multicentre clinical cohort comprised 55,615 patients treated between 2005-2025 across nine fertility clinics in the UK, including both private and public (NHS) care. Together, these data enabled comparison of pre-treatment characteristics, treatment responses, and pregnancy outcomes across ethnic groups. Participants/materials, setting, methods Live birth rate (primary outcome) after first fresh IVF/ICSI cycle, and after first FET, were compared by ethnic group. Pre-treatment prognostic factors, socioeconomic indicators (multiple deprivation decile and funding source), response to ovarian stimulation, and pregnancy outcomes were analysed. Ethnic minority groups (Black, East/Other Asian, South Asian) were compared with White patients as the reference group. Logistic regression was used to calculate adjusted odds ratios for fresh and FET cycles. Main results and the role of chance In HFEA registry data (Cohort 1), Black (35.1yrs) and East/Other Asian patients (34.9yrs) accessed first IVF treatment at older ages than White patients (34.4yrs), whereas South Asian patients were younger (33.2yrs) (p<0.001). Median BMI was higher in Black (26.7kg/m²) than White (24.8kg/m²) and South Asian patients (25.0kg/m²), and lowest in East/Other Asian patients (23.1kg/m²) (p<0.001). In Cohort 2, ethnic minority groups were more socioeconomically disadvantaged (median multiple deprivation decile: White 7 vs. ethnic minority groups 4–5; p<0.001) and more frequently NHS-funded (White 50% vs. ethnic minority groups 66–73%; p<0.001). In HFEA data, the adjusted odds ratios for live birth after fresh embryo transfer were: Black 0.52 (95%CI 0.50–0.55), East/Other Asian 0.72 (0.69–0.75), South Asian 0.72 (0.70–0.74) (all p<0.001). Disparities were apparent as early as biochemical pregnancy, with broadly similar miscarriage rates. In Cohort 2 FET cycles, reduced live birth odds were partly attenuated: Black 0.77 (95%CI 0.59–1.01; p=0.06), East/Other Asian 0.84 (0.70–1.01; p=0.07), South Asian 0.71 (0.62–0.82; p<0.001). Ethnic differences were also observed in response to ovarian stimulation. Black patients had reduced oocyte maturation and fertilisation rates, resulting in fewer mature oocytes and embryos. Despite this, the number of embryos transferred and their quality was similar, suggesting abnormal implantation as a key factor. Limitations, reasons for caution As this is a retrospective observational analysis, there may yet remain residual confounding due to unmeasured biological, behavioural, or pathway factors, which contribute to observed disparities and limit causal interpretation. Ethnicity was self-reported and grouped into broad categories that may not capture the full effect of granular ethnic diversity. Wider implications of the findings Our data show that ethnic disparities in IVF outcomes persist even after adjustment for known pre-treatment and socioeconomic confounders. Further research is now urgently warranted to investigate the causes, to assess how these disparities can be reduced to ensure equitable IVF outcomes for patients from all backgrounds. Trial registration number No
Zitieren
APA
Hanassab, S., Sheremetyeva, E., Ng, A., Machiyama, K., Loukily, E., Nelson, S., Saravelos, S., Salim, R., Comninos, A., Trew, G., Evans, A., Heinis, T., Parbhoo, S., Dhillo, W., & Abbara, A. (2026). L26/P-454 Marked ethnic disparities in IVF outcomes result in significantly reduced live birth rates in ethnic minority groups. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.788
Vancouver
Hanassab S, Sheremetyeva E, Ng A, Machiyama K, Loukily E, Nelson S, et al. L26/P-454 Marked ethnic disparities in IVF outcomes result in significantly reduced live birth rates in ethnic minority groups. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.788
BibTeX
@article{Hanassab2026,
author = {Hanassab, S. and Sheremetyeva, E. and Ng, A. and Machiyama, K. and Loukily, E. and Nelson, S.M. and Saravelos, S. and Salim, R. and Comninos, A.N. and Trew, G.H. and Evans, A. and Heinis, T. and Parbhoo, S. and Dhillo, W.S. and Abbara, A.},
title = {L26/P-454 Marked ethnic disparities in IVF outcomes result in significantly reduced live birth rates in ethnic minority groups},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.788}
}
EUVIMED